Pancreatic Cell News Volume 11.44 | Dec 8 2020

    0
    47







    2020-12-08 | PACN 11.45


    Pancreatic Cell News by STEMCELL Technologies
    Vol. 11.44 – 8 December, 2020
    TOP STORY

    Pancreas-Specific SNAP23 Depletion Prevents Pancreatitis by Attenuating Pathological Basolateral Exocytosis and Formation of Trypsin-Activating Autolysosomes

    In vitro pancreatitis induction by supraphysiological cholecystokinin (CCK) or ethanol plus low-dose CCK were used to assess SNAP23-KD effects on exocytosis and autophagy.
    [Autophagy]

    Abstract
    Organoids: Nature Research Round Table
    PUBLICATIONSRanked by the impact factor of the journal
    DIABETES & PANCREATITIS

    Loss of Furin in β cells Induces an mTORC1-ATF4 Anabolic Pathway that Leads to β cell Dysfunction

    Investigators showed that FURIN was highly expressed in human islets, while proprotein convertase that potentially could provide redundancy were expressed at considerably lower levels.
    [Diabetes]

    Abstract

    Early Macrophage Infiltrates Impair Pancreatic Cancer Cell Growth by TNF-α Secretion

    In vitro BrdU proliferation and Annexin V cell death analyses were performed on PANC-1 and MIA PaCa-2 PDAC cell lines exposed to conditioned medium of different macrophage subsets.
    [BMC Cancer]

    Full Article

    Clusterin Protects Lipotoxicity-Induced Apoptosis via Upregulation of Autophagy in Insulin-Secreting Cells

    Treatment with clusterin remarkably upregulated microtubule-associated protein 1-light chain 3 (LC3)-II conversion in a dose and time-dependent manner with a significant increase in the autophagy-related 3 gene expression level, which is a mediator of LC3-II conversion.
    [Endocrinology and Metabolism]

    Abstract

    Heterogeneous Expression of CFTR in Insulin-Secreting β-Cells of the Normal Human Islet

    Researchers used immunofluorescence confocal and immunofluorescence microscopy, immunohistochemistry, RT-qPCR, Western blotting, pharmacology, electrophysiology and insulin secretory studies in normal human, rat and mouse islets.
    [PLoS One]

    Full Article

    PANCREATIC CANCER

    Composition, Spatial Characteristics, and Prognostic Significance of Myeloid Cell Infiltration in Pancreatic Cancer

    To generate spatially-resolved tumor and immune cell data at single cell resolution, investigators developed two quantitative multiplex immunofluorescence assays to interrogate myeloid cells and macrophages in the pancreatic ductal carcinoma tumor microenvironment.
    [Clinical Cancer Research]

    Abstract

    Selective Inhibition of Stemness through EGFR/FOXA2/SOX9 Axis Reduces Pancreatic Cancer Metastasis

    Afatinib alone or in combination with gemcitabine decreased stemness and tumorspheres by reducing phosphorylation of EGFR family proteins, ERK, FAK, and cancer stem cell (CSC) markers. Mechanistically, afatinib treatment decreased CSC markers by downregulating SOX9 via FOXA2.
    [Oncogene]

    Abstract

    Soluble VCAM-1 Promotes Gemcitabine Resistance via Macrophage Infiltration and Predicts Therapeutic Response in Pancreatic Cancer

    Subcutaneous allograft tumors with overexpression or knock-down of vascular cell adhesion molecule-1 (VCAM-1), as well as VCAM-1-blocking treatment in the spontaneous mouse model of pancreatic cancer, revealed that sVCAM-1 promoted tumor growth and resistance to gemcitabine treatment in vivo but not in vitro.
    [Scientific Reports]

    Full Article

    Dr. Sylvia Boj discusses how organoids are revolutionizing drug screening for cystic fibrosis in this webinar
    REVIEWS

    Nerve Fibers in the Tumor Microenvironment in Neurotropic Cancer- Pancreatic Cancer and Cholangiocarcinoma

    Scientists discuss nerve fiber crosstalk with the main different components of the tumor microenvironment, the immune cells, and the fibroblasts. They also discuss the crosstalk between the nerve fibers and the cancer.
    [Oncogene]

    Full Article

    Targeting HGF/c-MET Axis in Pancreatic Cancer

    The authors discuss the role of the MET/hepatocyte growth factor (HGF) axis in tumor progression and dissemination of pancreatic cancer. Therapeutic approaches that were developed targeting either the ligand or the receptor have not been shown to translate well into clinical settings.
    [International Journal of Molecular Sciences]

    Full Article
    INDUSTRY AND POLICY NEWS

    AB Science Announces That Confirmatory Phase III Study AB12005 with Masitinib in First Line Pancreatic Cancer with Pain Met Its Primary Objective to Demonstrate Increase in Survival

    AB Science SA announced that its Phase III study met its primary objective to demonstrate increase in survival in pancreatic cancer with pain. Study AB12005 evaluated masitinib 6.0 mg/kg/day in combination with gemcitabine in first-line treatment of unresectable locally advanced or metastatic pancreatic cancer patients with pain.
    [Nature Reviews Drug Discovery]

    Press Release

    Henry Ford Health System Receives $16 Million Gift to Benefit Henry Ford Pancreatic Cancer Center

    Henry Ford Health System announced a $16 million gift to its Henry Ford Pancreatic Cancer Center, which was launched in 2018 by an initial $20 million gift from the same donor, who wishes to remain anonymous. The gift will bolster the HFPCC’s clinical and translational research endeavors in the fight against this devastating disease, for which the five-year survival rate is only 9%.
    [Henry Ford Health System]

    Press Release

    FEATURED EVENT

    Eradicate Cancer

    January 15 – 16, 2021
    Virtual

    > See All Events

    JOB OPPORTUNITIES

    Associate Professor – Cancer Biology

    University of Cincinnati – Cincinnati, Ohio, United States

    Senior Investigator – Replication Stress and Chromatin Alterations

    NIH National Cancer Institute – Bethesda, Maryland, United States

    Postdoctoral Fellow – Pancreatic Beta Cell Biology

    Harvard Joslin Diabetes Center – Boston, Massachusetts, United States

    Postdoctoral Fellowship – Diabetes Mellitus and Islet Biology

    University of Michigan – Ann Arbor, Michigan, United States

    Research Professional – Life Sciences

    Stanford University – Stanford, California, United States

    > See All Jobs

    Submit an article, publication, job or event
    Brought to you by
    stemcell-logo-for newsletter-2
    Science News Pancreatic Cell News Archives Contact Us
    Pancreatic Cell News Twitter